Hepatitis C and the Risk of Kidney Disease and Mortality in Veterans With HIV

被引:35
|
作者
Fischer, Michael J. [1 ,2 ]
Wyatt, Christina M. [3 ]
Gordon, Kirsha [4 ]
Gibert, Cynthia L. [5 ]
Brown, Sheldon T. [6 ]
Rimland, David [7 ]
Rodriguez-Barradas, Maria C. [8 ]
Justice, Amy C. [4 ,9 ,10 ]
Parikh, Chirag R. [4 ,11 ]
机构
[1] Univ Illinois, Dept Med, Nephrol Sect, Jesse Brown VA Med Ctr, Chicago, IL 60612 USA
[2] Hines VA Hosp, Ctr Management Complex Chron Care, Hines, IL USA
[3] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY USA
[4] W Haven VA Med Ctr, New Haven, CT USA
[5] George Washington Univ, Div Infect Dis, Dept Med, VA Med Ctr,Med Ctr, Washington, DC 20037 USA
[6] Mt Sinai Sch Med, Dept Med, Infect Dis Sect, James J Peters VA Med Ctr, New York, NY USA
[7] Atlanta VA Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA USA
[8] Baylor Coll Med, Dept Med, Infect Dis Sect, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA
[9] Yale Univ, Dept Med, Sch Med, New Haven, CT 06520 USA
[10] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA
[11] Yale Univ, Dept Med, Nephrol Sect, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
death; HIV; hepatitis C; kidney failure; veterans; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC-RENAL-FAILURE; INFECTED PATIENTS; COINFECTION; PROGRESSION; IMPACT; ASSOCIATION; RATES; MORBIDITY;
D O I
10.1097/QAI.0b013e3181b980d4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To examine the effect of hepatitis C virus (HCV) oil the prevalence of chronic kidney disease (CKD) among veterans with HIV and to evaluate independent associations of HCV and CKD with mortality. Methods: We studied a national cohort of HIV-infected patients receiving care through the Veterans Healthcare Administration from 1998 to 2004. CKD was defined as an estimated glomerular filtration rate [eGFR (mL/min/1.73 m(2))] < 60. Poisson regression was used to assess relationships between CKD, HCV, and mortality. Results: Among 23,155 HIV-infected veterans, 12% had CKD. Forty percent of the cohort was coinfected with HCV, and a higher proportion of coinfected subjects had CKD compared with monoinfected subjects (14% vs 11%, P < 0.001). During the median follow-up of 7.6 years, 37% of subjects died and a graduated increase in adjusted mortality rates occurred with lower levels of eGFR (P < 0.001). Adjusted mortality rates were consistently higher in HCV-coinfected subjects across all levels of eGFR (P < 0.001). HCV was independently associated with increased mortality (incidence rate ratio 1.23, 95% confidence interval 1.17-1.29). Conclusions: CKD is prevalent in HIV-infected veterans and associated with substantially higher mortality. Compared with their monoinfected counterparts, veterans coinfected with HCV have significantly higher rates of CKD and mortality.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 50 条
  • [1] The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis C
    Freiberg, Matthew S.
    Chang, Chung-Chou H.
    Skanderson, Melissa
    McGinnis, Kathleen
    Kuller, Lewis H.
    Kraemer, Kevin L.
    Rimland, David
    Goetz, Matthew B.
    Butt, Adeel A.
    Barradas, Maria C. Rodriguez
    Gibert, Cynthia
    Leaf, David
    Brown, Sheldon T.
    Samet, Jeffrey
    Kazis, Lewis
    Bryant, Kendall
    Justice, Amy C.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04): : 425 - 432
  • [2] Hepatitis C Viremia and the Risk of Chronic Kidney Disease in HIV-Infected Individuals
    Lucas, Gregory M.
    Jing, Yuezhou
    Sulkowski, Mark
    Abraham, Alison G.
    Estrella, Michelle M.
    Atta, Mohamed G.
    Fine, Derek M.
    Klein, Marina B.
    Silverberg, Michael J.
    Gill, M. John
    Moore, Richard D.
    Gebo, Kelly A.
    Sterling, Timothy R.
    Butt, Adeel A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (08): : 1240 - 1249
  • [3] Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population
    Kakinami, L.
    Block, R. C.
    Adams, M. J.
    Cohn, S. E.
    Maliakkal, B.
    Fisher, S. G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (01) : 6 - 13
  • [4] Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV
    Mathur, Poonam
    Ramadhani, Habib O.
    Kaplan, Roman
    Stafford, Kristen A.
    Theppote, Amanda
    Wilson, Eleanor
    [J]. AIDS, 2024, 38 (09) : 1437 - 1439
  • [5] Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons
    Mocroft, Amanda
    Ryom, Lene
    Oprea, Cristiana
    Li, Qiuju
    Rauch, Andri
    Boesecke, Christoph
    Uzdaviniene, Vilma
    Sedlacek, Dalibor
    Llibre, Josep M.
    Lacombe, Karine
    Nielsen, Lars N.
    Florence, Eric
    Aho, Inka
    Chkhartishvili, Nikoloz
    Szlavik, Janos
    Dragovic, Gordana
    Leen, Clifford
    Sambatakou, Helen
    Staub, Therese
    Laguno, Montse
    Elinav, Hila
    Peters, Lars
    [J]. AIDS, 2020, 34 (10) : 1485 - 1495
  • [6] The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US. Veterans with hepatitis C
    Kramer, JR
    Giordano, TP
    Souchek, J
    Richardson, P
    Hwang, LY
    El-Serag, HB
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01): : 56 - 63
  • [7] Race, Kidney Disease Progression, and Mortality Risk in HIV-Infected Persons
    Alves, Tahira P.
    Hulgan, Todd
    Wu, Pingsheng
    Sterling, Timothy R.
    Stinnette, Samuel E.
    Rebeiro, Peter F.
    Vincz, Andrew J.
    Bruce, Marino
    Ikizler, T. Alp
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12): : 2269 - 2275
  • [8] Viral infections and the kidney: HIV, hepatitis B, and hepatitis C
    Appel, Gerald
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2007, 74 (05) : 353 - 360
  • [9] Influence of HCV co-infection and hepatitis C treatment on risk of chronic kidney disease in HIV positive persons
    Peters, L.
    Ryom, L.
    Oprea, C.
    Li, Q.
    Rauch, A.
    Boesecke, C.
    Uzdaviniene, V.
    Sedlacek, D.
    Llibre, J.
    Lacombe, K.
    Nielsen, L.
    Florence, E.
    Aho, I.
    Chkhartishvili, N.
    Szlavik, J.
    Dragovic, G.
    Leen, C.
    Sambatakou, H.
    Staub, T.
    Laguno, M.
    Elinav, H.
    Tomazic, J.
    Mocroft, A.
    [J]. HIV MEDICINE, 2019, 20 : 192 - 193